Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in finland: A randomized trial

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 9, 2011, Pages 1960-1969

  Virtanen, Anni ^a   Nieminen, Pekka ^b   Luostarinen, Tapio ^a   Anttila, Ahti ^a  

^a FINNISH CANCER REGISTRY   (Finland)

^b JORVI HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FEMALE; FINLAND; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SELF EVALUATION; SELF SAMPLING HUMAN PAPILLOMAVIRUS TEST; SERODIAGNOSIS; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; EARLY DETECTION OF CANCER; FEMALE; FINLAND; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SELF-EXAMINATION; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 80052523224     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0307     Document Type: Article

References (45)

1. Segnan N., Senore C., Giordano L., Ponti A., Ronco G. Promoting participation in a population screening program for breast and cervical cancer: A randomized trial of different invitation strategies. Tumori 1998;84:348-353 (Pubitemid 28313354)
2. Kupets R., Covens A. Strategies for the implementation of cervical and breast cancer screening of women by primary care physicians. Gynecol Oncol 2001;83:186-197 (Pubitemid 33033053)
3. Eaker S., Adami H.O., Granath F., Wilander E., Sparen P. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev 2004;13:346-354 (Pubitemid 38737457)
4. Working Group Set up by the Finnish Medical Society Duodecim. Diagnosis, treatment and follow-up of cytological changes in the cervix, vagina and vulva. Current care guideline. Helsinki, Finland: Finnish Medical Society Duodecim. 2010 [cited 2011 Mar 28]. Available from: www.kaypahoito.fi.
5. Finnish Cancer Registry, statistics. Available from: www.cancerregistry. fi/statistics.
6. Nieminen P., Kallio M., Anttila A., Hakama M. Organised vs. spontaneous pap-smear screening for cervical cancer: A case-control study. Int J Cancer 1999;83:55-58 (Pubitemid 29409477)
7. Sellors J.W., Lorincz A.T., Mahony J.B., Mielzynska I., Lytwyn A., Roth P., et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ 2000;163:513-518
8. Wright T.C. Jr, Denny L., Kuhn L., Pollack A., Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000;283:81-86 (Pubitemid 30038387)
9. Nobbenhuis M.A., Helmerhorst T.J., Van den Brule A.J., Rozendaal L., Jaspars L.H., Voorhorst F.J., et al. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol 2002;55:435-439 (Pubitemid 34620780)
10. Belinson J.L., Qiao Y.L., Pretorius R.G., Zhang W.H., Rong S.D., Huang M.N., et al. Shanxi province cervical cancer screening study II: Self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Int J Gynecol Cancer 2003;13:819-826 (Pubitemid 38235227)
11. Szarewski A., Cadman L., Mallett S., Austin J., Londesborough P., Waller J., et al. Human papillomavirus testing by self-sampling: Assessment of accuracy in an unsupervised clinical setting. J Med Screen 2007;14:34-42. (Pubitemid 46440364)
12. Bidus M.A., Zahn C.M., Maxwell G.L., Rodriguez M., Elkas J.C., Rose G.S. The role of self-collection devices for cytology and human papillomavirus DNA testing in cervical cancer screening. Clin Obstet Gynecol 2005;48:127-132 (Pubitemid 40354382)
13. Bhatla N., Dar L., Patro A.R., Kumar P., Kriplani A., Gulati A., et al. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? Cancer Epidemiol 2009;33:446-450
14. Balasubramanian A., Kulasingam S.L., Baer A., Hughes J.P., Myers E.R., Mao C., et al. Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. J Low Genit Tract Dis 2010;14:185-195
15. Belinson J.L., Hu S., Niyazi M., Pretorius R.G., Wang H., Wen C., et al. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection. Int J Cancer 2010;127:1151-1157
16. Bais A.G., Van Kemenade F.J., Berkhof J., Verheijen R.H., Snijders P.J., Voorhorst F., et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs. Int J Cancer 2007;120:1505-1510 (Pubitemid 46355385)
17. Stenvall H., Wikstrom I., Wilander E. High prevalence of oncogenic human papilloma virus in women not attending organized cytological screening. Acta Derm Venereol 2007;87:243-245 (Pubitemid 47226893)
18. Sanner K., Wikstrom I., Strand A., Lindell M., Wilander E. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer 2009;101:871-874
19. Gok M., Heideman D.A.M., Van Kemenade F.J., Berkhof J., Rozendaal L., Spruyt J.W.M., et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: Cohort study. BMJ 2010;340:c1040.
20. Giorgi Rossi P., Marsili L.M., Camilloni L., Iossa A., Lattanzi A., Sani C., et al. The effect of self-sampled HPV-testing on participation to cervical cancer screening in Italy: A randomised controlled trial (IRSCTN96071600). Br J Cancer 2011;104:248-254
21. Virtanen A., Anttila A., Luostarinen T., Nieminen P. Self-sampling versus reminder letter: Effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer 2011;128:2681-2687
22. Kotaniemi-Talonen L., Nieminen P., Anttila A., Hakama M. Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting. Br J Cancer 2005;93:862-867 (Pubitemid 41487010)
23. Anttila A., Hakama M., Kotaniemi-Talonen L., Nieminen P. Alternative technologies in cervical cancer screening: A randomised evaluation trial. BMC Public Health 2006;6:252.
24. Leinonen M., Kotaniemi-Talonen L., Anttila A., Dyba T., Tarkkanen J., Nieminen P. Prevalence of oncogenic human papillomavirus infection in an organised screening population in Finland. Int J Cancer 2008;123:1344-1349
25. Anttila A., Kotaniemi-Talonen L., Leinonen M., Hakama M., Laurila P., Tarkkanen J., et al. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: Randomised study within organised screening programme. BMJ 2010;340:1804.
26. Brink A.A., Meijer C.J., Wiegerinck M.A., Nieboer T.E., Kruitwagen R.F., Van Kemenade F., et al. High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush. J Clin Microbiol 2006;44:2518-2523 (Pubitemid 44092421)
27. Leinonen M., Nieminen P., Kotaniemi-Talonen L., Malila N., Tarkkanen J., Laurila P., et al. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst 2009;101:1612-1623
28. Szarewski A., Cadman L., Mesher D., Austin J., Ashdown-Barr L., Edwards R., et al. HPV self-sampling as an alternative strategy in non-attenders for cervical screening-a randomised controlled trial. Br J Cancer 2011;104:915-920
29. Hillemanns P., Kimmig R., Hüttemann U, Dannecker C, J Thaler C. Screening for cervical neoplasia by self-assessment for human papillomavirus DNA. Lancet 1999;354:1970-1970.
30. Karwalajtys T., Howard M., Sellors J.W., Kaczorowski J. Vaginal self sampling versus physician cervical sampling for HPV among younger and older women. Sex Transm Infect 2006;82:337-339 (Pubitemid 44229454)
31. Khanna N., Mishra S.I., Tian G., Tan M.T., Arnold S., Lee C., et al. Human papillomavirus detection in self-collected vaginal specimens and matched clinician-collected cervical specimens. Int J Gynecol Cancer 2007;17:615-622 (Pubitemid 46744000)
32. Winer R.L., Feng Q., Hughes J.P., Yu M., Kiviat N.B., O'Reilly S., et al. Concordance of self-collected and clinician-collected swab samples for detecting human papillomavirus DNA in women 18 to 32 years of age. Sex Transm Dis 2007;34:371-377 (Pubitemid 46816783)
33. Gravitt P.E., Lacey J.V. Jr, Brinton L.A., Barnes W.A., Kornegay J.R., Greenberg M.D., et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 2001;10:95-100. (Pubitemid 32172426)
34. Castle P.E., Rodriguez A.C., Porras C., Herrero R., Schiffman M., Gonzalez P., et al. A comparison of cervical and vaginal human papillomavirus. Sex Transm Dis 2007;34:849-855 (Pubitemid 350301046)
35. Winer R.L., Hughes J.P., Feng Q., O'Reilly S., Kiviat N.B., Koutsky L.A. Comparison of incident cervical and vulvar/vaginal human papillomavirus infections in newly sexually active young women. J Infect Dis 2009;199:815-818
36. Peyton C.L., Schiffman M., Lorincz A.T., Hunt W.C., Mielzynska I., Bratti C., et al. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 1998;36:3248-3254 (Pubitemid 28476174)
37. Vernon S.D., Unger E.R., Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol 2000;38:651-655 (Pubitemid 30082658)
38. Castle P.E., Schiffman M., Burk R.D., Wacholder S., Hildesheim A., Herrero R., et al. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev 2002;11:1394-1399 (Pubitemid 35340375)
39. Poljak M., Marin I.J., Seme K., Vince A. Hybrid capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 2002;25:89-97.
40. Petignat P., Faltin D.L., Bruchim I., Tramer M.R., Franco E.L., Coutlee F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 2007;105:530-535 (Pubitemid 46590347)
41. Castle P.E., Solomon D., Wheeler C.M., Gravitt P.E., Wacholder S., Schiffman M. Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol 2008;46:2595-2604
42. Anttila A., Pokhrel A., Kotaniemi-Talonen L., Hakama M., Malila N., Nieminen P. Cervical cancer patterns with automation-assisted and conventional cytological screening: A randomized study. Int J Cancer 2011;128:1204-1212
43. Garcia F., Barker B., Santos C., Brown E.M., Nuño T., Giuliano A., et al. Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus. Obstet Gynecol 2003;102:266-272 (Pubitemid 36936997)
44. Longatto-Filho A., Roteli-Martins C., Hammes L., Etlinger D., Pereira S.M., Erzen M., et al. Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option. Experience from the LAMS study. Eur J Gynaecol Oncol 2008;29:327-332
45. Sowjanya A.P., Paul P., Vedantham H., Ramakrishna G., Vidyadhari D., Vijayaraghavan K., et al. Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India. Cancer Epidemiol Biomarkers Prev 2009;18:1373-1378